Maridebart Cafraglutide
MARITIME-2
Amgen · Phase 3 · Active, not recruiting · Enrollment 1105
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart Cafraglutide High Dose | Obesity + T2D | n/r | n/r | n/r | n/r |
| Maridebart Cafraglutide Medium Dose | Obesity + T2D | n/r | n/r | n/r | n/r |
| Maridebart Cafraglutide Low Dose | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |